LearnTransfusion Series

Assessing Eligibility of Donors with Coronary Artery Disease and Overview of Recent Donor Criteria Changes

Quand: 
6 novembre, 2018 | 12:00 - 13:00 (EDT)
Où: 

Toronto/Webinar

Speaker:

Dr. Peter Lesley, 

Medical Officer, Canadian Blood Services, Medical Services - East

Objectives:

1. Outline the principles and process for assessing donor medical eligibility and how the Donor Selection Criterian Manual (DSCM) is medically updated.
2. Outline the project undertaken to update the DSCM Donors with CAD criterion.
3. Discuss other recent medical updates to the DSCM and their impact on maintaining and enhancing CBS blood product availability.

 

References:

CAD References

1.  Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Popovsky MA, Whitaker B, Arnold NL.  Transfusion. 1995 Sep;35(9):734-7.PMID: 7570932

2.  Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Popovsky MA, Whitaker B, Arnold NL.  Transfusion. 1995 Sep;35(9):734-7.PMID: 7570932

3.  Blood donation and risk of coronary heart disease in men.  Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ.  Circulation. 2001 Jan 2;103(1):52-7. PMID: 1136685

4.  Allogeneic and autologous blood donor selection.  Eder AF, Muniz MDLA.  AABB Technical Manual Eighteenth Edition, Chapter 5, pg 129

5.  Safety of autologous blood donation prior to elective surgery for a variety of potentially "high-risk" patients.  Mann M, Sacks HJ, Goldfinger D.  Transfusion. 1983 May-Jun;23(3):229-32. PMID: 6602407

6.  All adverse events in autologous blood donors and cardiac disease are not necessarily caused by blood donation.  Kasper SM, Ellering J, Stachwitz P, Lynch J, Grunenberg R, Buzello W.  Transfusion.  1998 Jul;38(7):669-73.  PMID: 9683106

7.  Confirmation of the safety of autologous blood donation by patients awaiting heart or lung transplantation.  A controlled study using hemodynamic monitoring.  Klapper E, Pepkowitz SH, Czer L, Inducil C, Scott L, Goldfinger D.  J Thorac Cardiovasc Surg. 1995 Dec;110(6):1594-9.  PMID: 8523868 Free Article

8.  Guide to the preparation, use and QA of Blood Components, 16th Edition, European Directorate for the Quality of Medicines and Health Care.  2011, pg 109, 149, 20

 

Donor Eligibility/Screening References

1.  Screening Blood Donors: Science, Reason, and the Donor History Questionnaire.  Eder A, Bianco C. Bethesda, MD: AABB Press, 2007. Print

2.  Blood Donor Health and Safety.  Eder A, Goldman M.  Bethesda, MD: AABB Press, 2009. Print

3.  Blood donor complications after whole-blood donation.  Newman BH.  Curr Opin Hematol. 2004 Sep;11(5):339-45.  Review.  PMID: 15666658

 

Note:  The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

 


To register for the event visit  LearnTransfusion series .
The LearnTransfusion series is the seminar of the  Areas of Focused Competency (AFC) -Diploma Program in Transfusion Medicine . The series, organized by Canadian Blood Services, is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.

 

Transfusion